Oral administration of poly‐γ‐glutamic acid prevents the development of atopic dermatitis in NC/Nga mice
Open Access
- 24 June 2013
- journal article
- letter
- Published by Wiley in Experimental Dermatology
- Vol. 22 (8) , 561-563
Abstract
Bacillus subtilis‐derived poly‐γ‐glutamic acid (γPGA) has demonstrated adjuvant activity in promoting Th1/Th17 cell differentiation. Here, the NC/Nga (NC) mouse model was used to determine whether γPGA modulates the outcome of atopic dermatitis (AD), which is known to be a Th2‐biased immune disease. We found that oral administration of γPGA dramatically reduced the development of AD in NC mice. Antigen‐presenting cells activated with γPGA produced pro‐inflammatory cytokines, such as IL12/23 and IFNγ, which, in turn, induced the differentiation of Th1 and Th17 cells. Concomitantly, Th2 responses, such as high levels of serum IgE, were dramatically decreased. Furthermore, in vivo γPGA treatment altered several cellular components of allergic reactions, such as mast cells and eosinophils. Taken together, our results strongly demonstrate that in vivo treatment with γPGA at early time points can prevent the development of AD in NC mice and suggest that γPGA may have therapeutic applications for human AD.Keywords
This publication has 20 references indexed in Scilit:
- Bacillus-derived poly-γ-glutamic acid attenuates allergic airway inflammation through a Toll-like receptor-4-dependent pathway in a murine model of asthmaClinical & Experimental Allergy, 2011
- T-cell Subset Regulation in AtopyCurrent Allergy and Asthma Reports, 2011
- New Biological Functions and Applications of High‐Molecular‐Mass Poly‐γ‐glutamic AcidChemistry & Biodiversity, 2010
- Cutting Edge: The Th1 Response Inhibits the Generation of Peripheral Regulatory T CellsThe Journal of Immunology, 2009
- Bacillus subtilis-specific poly- -glutamic acid regulates development pathways of naive CD4+ T cells through antigen-presenting cell-dependent and -independent mechanismsInternational Immunology, 2009
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Natural and edible biopolymer poly‐γ‐glutamic acid: synthesis, production, and applicationsThe Chemical Record, 2005
- Toll-like receptors and immune response in allergic diseaseClinical Reviews in Allergy & Immunology, 2004
- Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administrationNature Medicine, 2004
- Decreased frequency of interferon‐γ‐ producing CD4+ cells in the peripheral blood of patients with atopic dermatitisExperimental Dermatology, 1998